By 1950, cardiovascular disease mortality was 450 per 100,000 inhabitants. The advent of new techniques, new drugs and the identification of risk factors have made this figure has been reduced by 300%. The cardiologist at Hospital Clínico San Carlos, Madrid, Carlos Macaya has reviewed the milestones of interventional cardiology on May 24 at a conference […]
What stage of evolution, the human brain developed the language and the ability to make music? What made us different from other primates? These are some of the questions that drive research Josef Rauschecker Department of Neuroscience at Georgetown University, Washington. Rauschecker explained their progress on May 17 at a conference cycle framed within IDIBELL
Researchers of the IDIBELL have developed a preclinical therapeutic model to test new treatments for brain metastases in breast cancer patients. The results of the study are published in the International Journal of Molecular Sciences. Brain metastasis affects 30% of breast cancer patients who develop metastases. Currently the treatment of choice is radiotherapy. Only in
One, two, three… many. Studies with neuroimaging techniques confirm that the representation we make of numbers follows this pattern. Humans have specialized neurons that activates in front of one thing, two things, and three things. The rest are approximate representations. Josep Marco, researcher at the group of Brain Plasticity and Cognition at IDIBELL and the
Josep Marco: ”we have an approximate system to measure amounts” Read More »
In Europe there are about 2 million people with minimal Hepatic Encephalopathy, 200,000 in Spain. Most of them are undiagnosed so that cannot prevent the progression of the disease with cognitive and motor impairment that this entails. Vicente Felipo, researcher at the Centre Prince Felipe of Valencia explained on May 10 his progress in the
The IDIBELL researcher Gabriel Capellá has been appointed new Head of Research and Innovation for Health of the Health Department of the Generalitat de Catalunya, replacing Marta Aymerich. Capellá will combine this task with the responsabilities of head of the Hereditary Cancer Program of the ICO and leader of the IDIBELL Hereditary Cancer group. From
Researcher of the Center for Molecular Genetic Diagnosis at the IDIBELL and the Oncogenetics Laboratory and Unit High Risk and Prevention Cancer of the Hospital Vall d’Hebron have studied a family affected by both type 1 neurofibromatosis and early breast cancer and they have detected mutations in NF1 and BRCA1 genes responsible for the two
On April 2nd Marga Frontera joined IDIBELL as scientific office manager. Her mission, in her own words, is “getting the researcher, as far as possible, do not worry about anything but to investigate”. Frontera knows the day-to-day work in the laboratory because she has worked as a postdoctoral researcher in the laboratory of genomic imprinting
Marga Frontera, new scientific office manager at IDIBELL Read More »
Heart failure is the leading cause of admission to hospital and one of the health problems that is growing as people live longer. The head of the Heart Failure and Cardiac Transplant Unit at the Bellvitge University Hospital and researcher at the Cardiovascular Diseases group at IDIBELL, Nicolás Manito, spoke about heart failure on May
Nicolás Manito: ”the new mechanical hearts save transplants” Read More »
Rauschecker leads the integrated neuroscience laboratory and Cognition at the University of Georgetown. His research focuses on understanding the neurophysiological mechanisms that differentiate us from other primate species and that have allowed us to develop throughout the evolution of music and speech. In this talk we will know the neural circuits in humans and monkeys
